Who are Enlivex's investors?

Enlivex's investors include Pontifax Venture Capital, Korea Investment Partners.

How much funding has Enlivex raised?

Enlivex has disclosed $212M raised across 1 of its 2 known rounds.

Enlivex

NASDAQ: ENLV

2 known investors

Find your way into Enlivex

Paths you didn't know you had: your email and LinkedIn already hold routes to the Enlivex team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Enlivex is a Nasdaq-listed clinical-stage biotech developing Allocetra, a macrophage reprogramming immunotherapy targeting age-related knee osteoarthritis to restore mobility and function in aging populations. The company also runs a treasury strategy anchored in RAIN, a prediction markets protocol on Arbitrum, offering public-market exposure to prediction market infrastructure.

Biotech Crypto & Web3 Longevity

Investors · 2

Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya

How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Korea Investment PartnersreportedSeoul · $3M – $10M

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$212M disclosed across 1 of 2 rounds · 1900–2025

$212MraisedNov 2025 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 10

StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.

RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.

Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

TipRanksFinancial analysis and stock research platform.

Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.

PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.

KrakenKraken 360 Investments provides capital and launch infrastructure to blockchain protocols in pre-token and early post-token phases, offering custody, staking, treasury, and liquidity services alongside fundraising support.

Enliven TherapeuticsEnliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology. Its discovery work combines clinically validated biological targets with differentiated chemistry to develop drugs for unmet medical needs.

Companies working in the same space as Enlivex.

Frequently asked questions

What does Enlivex do?: Enlivex is a Nasdaq-listed clinical-stage biotech developing Allocetra, a macrophage reprogramming immunotherapy targeting age-related knee osteoarthritis to restore mobility and function in aging populations. The company also runs a treasury strategy anchored in RAIN, a prediction markets protocol on Arbitrum, offering public-market exposure to prediction market infrastructure.
Who are Enlivex's investors?: Enlivex's investors include Pontifax Venture Capital, Korea Investment Partners.
How much funding has Enlivex raised?: Enlivex has disclosed $212M raised across 1 of its 2 known rounds.